Clorox Reports Q4 and Fiscal Year 2020 Results, Provides Fiscal Year 2021 Outlook
Clorox Company (NYSE: CLX) reported strong financial results for Q4 and fiscal year 2020, with a 22% sales increase and a 28% rise in diluted EPS to $2.41. Total sales for the fiscal year grew by 8%, with diluted EPS increasing by 16% to $7.36. The company experienced double-digit growth across all segments, driven by heightened demand for cleaning products amid the COVID-19 pandemic. Clorox also forecasted flat to low single-digit sales growth for fiscal year 2021, citing uncertainty due to ongoing pandemic impacts.
- 22% sales increase in Q4 2020.
- 28% increase in diluted EPS to $2.41 for Q4 2020.
- 8% sales growth for fiscal year 2020.
- 16% increase in diluted EPS to $7.36 for fiscal year 2020.
- Gross margin rose by 170 basis points to 45.6% for fiscal year 2020.
- Increased operational cash flow to $1.5 billion, a 56% rise from FY 2019.
- Acquired a majority stake in a joint venture in Saudi Arabia for $100 million.
- Expectations for flat to low single-digit sales growth in fiscal year 2021.
- Potential challenges from increased taxes and foreign exchange rates affecting EPS.
OAKLAND, Calif., Aug. 3, 2020 /PRNewswire/ -- The Clorox Company (NYSE: CLX) reported a
"I'm pleased that we've delivered a quarter of exceptional results, fueled by strong demand for our products that we've been privileged to provide in support of public health and to serve some of the essential needs of consumers as they've had to stay at home more," said Clorox Chair and CEO Benno Dorer. "These results could not have been possible without dedication and strong execution by our people, who have always been guided by our core value Do the Right Thing."
Dorer added: "Guided by our IGNITE Strategy, we remain committed to building on this momentum through deliberate and aggressive investments to support our ambition of accelerating long-term sales growth."
This press release includes some non-GAAP financial measures. See "Non-GAAP Financial Information" at the end of this press release for more information.
Fiscal Fourth-Quarter Results
Following is a summary of key fourth-quarter results. All comparisons are with the fourth quarter of fiscal year 2019, unless otherwise stated.
22% sales increase$2.41 diluted EPS (28% increase versus year-ago quarter)
In the fourth quarter, sales increased
The company's fourth-quarter gross margin increased 170 basis points to
Clorox delivered earnings of
Key Segment Results
In the fourth quarter of fiscal year 2020, the company realigned its reportable segments following operational and systems integration. The Digestive Health and Dietary Supplements business units were combined into a new Vitamins, Minerals and Supplements business unit, and the Laundry and Home Care business units were combined to create the Cleaning business unit. These newly established business units, along with the Professional Products business unit, now make up the new Health and Wellness reportable segment due to their shared economic and qualitative characteristics.2
Following is a summary of key fourth-quarter results based on the new reportable segment structure. All comparisons are with the fourth quarter of fiscal year 2019, unless otherwise stated. Net sales and earnings (losses) before income taxes for relevant periods in the last three fiscal years have been recast and are available in the Investors section of The Clorox Company website.
Health and Wellness (Cleaning; Professional Products; Vitamins, Minerals and Supplements)
33% sales increase84% pretax earnings increase
Segment sales were up behind double-digit growth in two of three business units. Growth was fueled by a broad-based increase in demand for disinfecting and cleaning products across the Cleaning and Professional Products portfolios related to COVID-19. The increase in pretax earnings was driven mainly by sales growth, which was partially offset by higher advertising investments and manufacturing and logistics costs.
Household (Bags and Wraps, Grilling, Cat Litter)
17% sales increase24% pretax earnings increase
Segment sales increased in all three businesses, driven mainly by double-digit growth in Bags and Wraps and Grilling, which both benefited from much stronger consumer demand, supported by innovation. Higher pretax earnings were due mainly to sales growth, which was partially offset by higher advertising investments and manufacturing and logistics costs.
Lifestyle (Food, Water Filtration, Natural Personal Care)
16% sales increase15% pretax earnings increase
Segment sales grew from double-digit increases in the Food and Water Filtration businesses, driven by higher consumer demand. Pretax earnings increased primarily behind higher sales, which were partially offset by increased manufacturing and logistics costs and advertising investments.
International (Sales Outside the U.S.)
12% sales increase (24% organic sales increase)47% pretax earnings decrease
Segment sales were up by double digits behind strong demand for cleaning and disinfecting products as well as other essential household products. Organic sales for International grew
Fiscal Year 2020 Results
Following is a summary of key fiscal year 2020 results:
8% sales growth$7.36 diluted EPS (16% increase)
In fiscal year 2020, Clorox delivered
Fiscal year gross margin rose by 170 basis points to
Net cash provided by operations was
Clorox Increases Stake in International JV
Clorox acquired a majority stake in its long-standing joint venture in the Kingdom of Saudi Arabia for a purchase price of
Clorox Provides Fiscal Year 2021 Outlook
- Flat to low single-digit increase in sales (flat to low single-digit increase in organic sales growth)
- Mid-single-digit decrease to mid-single-digit increase in diluted EPS
Clorox believes it is important to provide management's current business perspective and financial outlook for fiscal year 2021, recognizing there is significant uncertainty about future COVID-19 impacts related to various areas of its business. Although the magnitude of future COVID-19 impacts on Clorox's fiscal year 2021 financial results remains uncertain, its outlook reflects the following current key assumptions:
- Continued elevated global demand for cleaning and disinfecting products.
- Aggressive investments in the long-term momentum in Clorox's global portfolio, including increasing production capacity.
- Job security and discretionary spending pressures on consumers as a result of an ongoing recession.
- Minimal disruptions to its extended supply chain and other operations, allowing Clorox to continue producing products to meet demand.
Clorox anticipates sales growth ranging from flat to low single digits, reflecting the expectation for continued elevated demand through the first half of the fiscal year and a deceleration in the back half from lapping of the initial spike in demand from COVID-19. Fiscal year 2021 sales reflect about 1 point of positive impact from the company's increased stake in its Kingdom of Saudi Arabia joint venture, offset by about 1 point of negative impact from foreign exchange rates, primarily in Argentina. Fiscal year organic sales are also expected to be in a range from flat to low single-digit growth.
Advertising and sales promotion spending is expected to increase to about
Clorox anticipates selling and administrative expenses to be about
The company's effective tax rate is expected to be in the range of
Net of all these factors, Clorox anticipates fiscal year 2021 diluted EPS range is expected to be from a mid-single-digit decrease to a mid-single-digit increase. The company's diluted EPS outlook includes an estimated contribution of 45 to 53 cents in fiscal year 2021 as a result of the company's increased stake in the Kingdom of Saudi Arabia joint venture, due primarily to a one-time non-cash gain associated with a fair value adjustment to the company's previously held stake, which will be recognized in the first quarter of fiscal year 2021. On a full year basis, this one-time gain will be offset by the company's expectations for a higher tax rate and foreign currency headwinds for the company.
"I'm pleased that we were able to deliver strong financial performance for both the fourth quarter and fiscal year 2020," said Chief Financial Officer Kevin Jacobsen. "Our focus now is building on this momentum, investing aggressively in brand-building and category growth as well as in production capacity to meet heightened demand. We feel confident these investments will allow us to capitalize on new opportunities, supporting our ambition to accelerate profitable growth and generate long-term shareholder value."
For More Detailed Financial Information
Visit the company's Financial Information: Quarterly Results section of the company's website at TheCloroxCompany.com for the following:
- Supplemental unaudited volume and sales growth information
- Supplemental unaudited gross margin driver information
- Supplemental unaudited cash flow information and free cash flow reconciliation
- Supplemental unaudited reconciliation of earnings before interest and taxes (EBIT)
- Supplemental schedule of recast net sales and earnings (losses) before income taxes of the company's reportable segments for the relevant periods in fiscal years 2020, 2019 and 2018
Note: Percentage and basis-point changes noted in this press release are calculated based on rounded numbers, except for per-share data and the effective tax rate. Supplemental materials are available in the Financial Information: Quarterly Results section of the company's website at TheCloroxCompany.com.
The Clorox Company
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of
Clorox is a signatory of the United Nations Global Compact and the Ellen MacArthur Foundation's New Plastics Economy Global Commitment. The company has been broadly recognized for its corporate responsibility efforts, named to the 2020 Axios Harris Poll 100 reputation rankings, Barron's 2020 100 Most Sustainable Companies list, and the Human Rights Campaign's 2020 Corporate Equality Index, among others. In support of its communities, The Clorox Company and its foundations contributed more than
CLX-F
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of governments, consumers, customers, suppliers, employees and the company, on our business, operations, employees, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may," "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "will," "predicts," and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations, or could affect the company's ability to achieve its strategic goals, are described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2019, as updated from time to time in the company's Securities and Exchange Commission filings. These factors include, but are not limited to, the uncertainties relating to the impact of COVID-19 on the company's business, operations, employees, financial condition and results of operations as well as: intense competition in the company's markets; the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences; volatility and increases in commodity costs such as resin, sodium hypochlorite and agricultural commodities, and increases in energy, transportation or other costs; the ability of the company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix; dependence on key customers and risks related to customer consolidation and ordering patterns; risks related to the company's use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or company information, or service interruptions; the company's ability to maintain its business reputation and the reputation of its brands and products; the impact of COVID-19 on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the company's products, including any disruption to such systems; long-term changes in consumer preference or demand for our products as a result of any shortages or lack of availability of any products in the near-term; risks related to supply chain issues and product shortages as a result of reliance on a limited base of suppliers and the significant increase in demand for disinfecting and other products due to the COVID-19 pandemic; risks relating to acquisitions, new ventures and divestitures, and associated costs, including the potential for asset impairment charges related to, among others, intangible assets and goodwill; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions; lower revenue, increased costs or reputational harm resulting from government actions and regulations; the ability of the company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity; uncertain worldwide, regional and local economic and financial market conditions, including as a result of fear of exposure to or actual impacts of a widespread disease outbreak, such as COVID-19; risks related to international operations and international trade, including foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls, including periodic changes in such controls; changes in U.S. immigration or trade policies, including the imposition of new or additional tariffs; labor claims and labor unrest; inflationary pressures, particularly in Argentina; political instability and the uncertainty regarding the outcome of Brexit; government-imposed price controls or other regulations; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action; the ability of the company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries; the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls; the ability of the company to implement and generate cost savings and efficiencies; the success of the company's business strategies; risks related to additional increases in the estimated fair value of The Procter & Gamble Company's interest in the Glad® business; the company's ability to attract and retain key personnel; environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; increased focus by governmental and non-governmental organizations, customers, consumers and investors on sustainability issues, including those related to climate change; the facilities of the company and its suppliers being subject to disruption by events beyond the company's control, including work stoppages, cyber-attacks, natural disasters, disease outbreaks or pandemics, such as COVID-19, and terrorism; the company's ability to maximize, assert and defend its intellectual property rights; any infringement or claimed infringement by the company of third-party intellectual property rights; the accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based; the effect of the company's indebtedness and credit rating on its business operations and financial results; the company's ability to access capital markets and other funding sources, as well as continued or increased market volatility; the company's ability to pay and declare dividends or repurchase its stock in the future; uncertainties relating to tax positions, tax disputes and changes in the company's tax rate, and any additional effects of the Tax Cuts and Jobs Act on the company; the company's ability to maintain an effective system of internal controls; the impacts of potential stockholder activism; and risks related to the company's discontinuation of operations in Venezuela.
The company's forward-looking statements in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this press release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
Non-GAAP Financial Information
- This press release contains non-GAAP financial information related to organic sales growth/(decrease) for the fourth quarter of fiscal year 2020 and for the fiscal year 2020 and organic sales growth outlook for fiscal year 2021. Clorox defines organic sales growth/(decrease) as GAAP net sales growth/(decrease) excluding the effect of foreign exchange rate changes and any acquisitions or divestitures.
- Organic sales growth outlook for fiscal year 2021 excludes the impact of unfavorable foreign currency exchange rates, which the company expects could reduce GAAP net sales growth by about 1 percentage point, and the impact of the company's increased stake in the Kingdom of Saudi Arabia joint venture, which the company expects could increase GAAP net sales growth by about 1 percentage point.
- Management believes that the presentation of organic sales growth/(decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the company was operating and expects to continue to operate throughout the relevant periods, and the company's estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the company and management. However, organic sales growth/(decrease) may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded.
The following tables provide reconciliations of organic sales growth/(decrease) (non-GAAP) to net sales growth/(decrease) (GAAP), the most comparable GAAP measure:
Three Months Ended June 30, 2020 | |||||||||
Percentage change versus the year-ago period | |||||||||
Health and | Household (1) | Lifestyle (1) | International | Total | |||||
Net sales growth / (decrease) (GAAP) | |||||||||
Add: Foreign Exchange | — | — | — | 12 | 2 | ||||
Add/(Subtract): Divestitures/Acquisitions | — | — | — | — | — | ||||
Organic sales growth / (decrease) (non- | |||||||||
Twelve Months Ended June 30, 2020 | |||||||||
Percentage change versus the year-ago period | |||||||||
Health and | Household (1) | Lifestyle (1) | International | Total | |||||
Net sales growth / (decrease) (GAAP) | |||||||||
Add: Foreign Exchange | — | — | — | 10 | 2 | ||||
Add/(Subtract): Divestitures/Acquisitions | — | — | — | — | — | ||||
Organic sales growth / (decrease) (non- | |||||||||
(1)In the fourth quarter of fiscal year 2020, the Digestive Health and Dietary Supplements business units were combined into a new Vitamins, Minerals and Supplements business unit, and the Laundry and Home Care business units were combined to create the Cleaning business unit. These newly established business units, along with the Professional Products business unit, now make up the new Health and Wellness reportable segment. Historical segment financial information presented has been recast to reflect this change. | |||||||||
For recent presentations made by company management and other investor materials, visit Investor Events on the company's website.
_________ | |
1 | Organic sales growth/(decrease) is a non-GAAP measure. See "Non-GAAP Financial Information" at the end of this press release, including the reconciliation of organic sales growth/(decrease) to net sales growth/(decrease), the most comparable GAAP measure. |
2 | The Digestive Health and Dietary Supplements business units were previously included in the Household and Lifestyle segments, respectively, and the Home Care and Laundry business units were previously included in the Cleaning segment. |
Condensed Consolidated Statements of Earnings | |||||||||||||
Dollars in millions, except share and per share data | |||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||
6/30/2020 | 6/30/2019 | 6/30/2020 | 6/30/2019 | ||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | |||||||||||
Net sales | $ | 1,983 | $ | 1,627 | $ | 6,721 | $ | 6,214 | |||||
Cost of products sold | 1,054 | 893 | 3,658 | 3,486 | |||||||||
Gross profit | 929 | 734 | 3,063 | 2,728 | |||||||||
Selling and administrative expenses | 279 | 217 | 969 | 856 | |||||||||
Advertising costs | 214 | 167 | 675 | 612 | |||||||||
Research and development costs | 42 | 38 | 145 | 136 | |||||||||
Interest expense | 25 | 25 | 99 | 97 | |||||||||
Other (income) expense, net | (26) | (5) | (10) | 3 | |||||||||
Earnings before income taxes | 395 | 292 | 1,185 | 1,024 | |||||||||
Income taxes | 85 | 51 | 246 | 204 | |||||||||
Net earnings | $ | 310 | $ | 241 | $ | 939 | $ | 820 | |||||
Net earnings per share | |||||||||||||
Basic net earnings per share | $ | 2.45 | $ | 1.91 | $ | 7.46 | $ | 6.42 | |||||
Diluted net earnings per share | $ | 2.41 | $ | 1.88 | $ | 7.36 | $ | 6.32 | |||||
Weighted average shares outstanding (in thousands) | |||||||||||||
Basic | 126,387 | 126,663 | 125,828 | 127,734 | |||||||||
Diluted | 128,494 | 128,423 | 127,671 | 129,792 | |||||||||
Reportable Segment Information | |||||||||||||||
(Unaudited) | |||||||||||||||
Dollars in millions | |||||||||||||||
Net sales | Earnings (losses) before income taxes | ||||||||||||||
Three Months Ended | Three Months Ended | ||||||||||||||
6/30/2020 | 6/30/2019 | % Change(1) | 6/30/2020 | 6/30/2019 | % Change(1) | ||||||||||
Health and Wellness (2) | $ | 805 | $ | 606 | $ | 252 | $ | 137 | |||||||
Household (2) | 612 | 525 | 157 | 127 | |||||||||||
Lifestyle (2) | 298 | 257 | 78 | 68 | |||||||||||
International | 268 | 239 | 10 | 19 | - | ||||||||||
Corporate | - | - | - | (102) | (59) | ||||||||||
Total | $ | 1,983 | $ | 1,627 | $ | 395 | $ | 292 | |||||||
Net sales | Earnings (losses) before income taxes | ||||||||||||||
Twelve Months Ended | Twelve Months Ended | ||||||||||||||
6/30/2020 | 6/30/2019 | % Change(1) | 6/30/2020 | 6/30/2019 | % Change(1) | ||||||||||
Health and Wellness (2) | $ | 2,749 | $ | 2,422 | $ | 766 | $ | 570 | |||||||
Household (2) | 1,795 | 1,774 | 347 | 337 | |||||||||||
Lifestyle (2) | 1,154 | 1,048 | 320 | 264 | |||||||||||
International | 1,023 | 970 | 116 | 96 | |||||||||||
Corporate | - | - | - | (364) | (243) | ||||||||||
Total | $ | 6,721 | $ | 6,214 | $ | 1,185 | $ | 1,024 | |||||||
(1) Percentages based on rounded numbers. | |||||||||||||||
(2)In the fourth quarter of fiscal year 2020, the Digestive Health and Dietary Supplements business units were combined into a new Vitamins, Minerals and Supplements business unit, and the Laundry and Home Care business units were combined to create the Cleaning business unit. These newly established business units, along with the Professional Products business unit, now make up the new Health and Wellness reportable segment. Historical segment financial information presented has been recast to reflect this change. | |||||||||||||||
Condensed Consolidated Balance Sheets | |||||||||
Dollars in millions | |||||||||
6/30/2020 | 6/30/2019 | ||||||||
(Unaudited) | |||||||||
ASSETS | |||||||||
Current assets | |||||||||
Cash and cash equivalents | $ | 871 | $ | 111 | |||||
Receivables, net | 648 | 631 | |||||||
Inventories, net | 454 | 512 | |||||||
Prepaid expenses and other current assets | 47 | 51 | |||||||
Total current assets | 2,020 | 1,305 | |||||||
Property, plant and equipment, net | 1,103 | 1,034 | |||||||
Operating lease right-of-use assets | 291 | - | |||||||
Goodwill | 1,577 | 1,591 | |||||||
Trademarks, net | 785 | 791 | |||||||
Other intangible assets, net | 109 | 121 | |||||||
Other assets | 328 | 274 | |||||||
Total assets | $ | 6,213 | $ | 5,116 | |||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||
Current liabilities | |||||||||
Notes and loans payable | $ | - | $ | 396 | |||||
Current operating lease liabilities | 64 | - | |||||||
Accounts payable and accrued liabilities | 1,329 | 1,035 | |||||||
Income taxes payable | 25 | 9 | |||||||
Total current liabilities | 1,418 | 1,440 | |||||||
Long-term debt | 2,780 | 2,287 | |||||||
Long-term operating lease liabilities | 278 | - | |||||||
Other liabilities | 767 | 780 | |||||||
Deferred income taxes | 62 | 50 | |||||||
Total liabilities | 5,305 | 4,557 | |||||||
Stockholders' equity | |||||||||
Preferred stock | - | - | |||||||
Common stock | 159 | 159 | |||||||
Additional paid-in capital | 1,137 | 1,046 | |||||||
Retained earnings | 3,567 | 3,150 | |||||||
Treasury shares | (3,315) | (3,194) | |||||||
Accumulated other comprehensive net (loss) income | (640) | (602) | |||||||
Stockholders' equity | 908 | 559 | |||||||
Total liabilities and stockholders' equity | $ | 6,213 | $ | 5,116 | |||||
View original content to download multimedia:http://www.prnewswire.com/news-releases/clorox-reports-q4-and-fiscal-year-2020-results-provides-fiscal-year-2021-outlook-301104416.html
SOURCE The Clorox Company
FAQ
What were Clorox's sales figures for Q4 2020?
How much did Clorox's diluted EPS increase in Q4 2020?
What are Clorox's sales expectations for fiscal year 2021?
What was Clorox's fiscal year 2020 sales growth percentage?
What factors contributed to Clorox's strong performance in FY 2020?
